Furthermore, we observed that patients with high E2F1 BC tumors exhibit both, better overall (Fig. 3b) and recurrence-free survival (Fig. 3c) upon increased APLF mRNA expression, whereas both worsen when APLF levels are low. Here, E2F1 is linked to breast cancer.